We are live on ! Find out more
TLSA icon

Tiziana Life Sciences

20 hedge funds and large institutions have $374K invested in Tiziana Life Sciences in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

0.02% more ownership

Funds ownership: 0.78%0.8% (+0.02%)

5% less funds holding

Funds holding: 2120 (-1)

16% less capital invested

Capital invested by funds: $443K → $374K (-$69.7K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

TLSA Hedge Fund Activity: Q1 2024 in Review

20 of the 6,959 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q1 2024, worth a combined $374K — down 16% from $443K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of TLSA and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.

The largest buyer was Envestnet Asset Management, opening a new position worth an estimated $8.8K. The largest seller was Cubist Systematic Strategies, exiting entirely with an estimated $6.78K sold.

  • 20 institutional investors held Tiziana Life Sciences (TLSA) as of Q1 2024, down from 21 in Q4 2023.
  • Funds reported $374K of Tiziana Life Sciences stock for Q1 2024, down 16% quarter-over-quarter.
  • 2 funds opened new Tiziana Life Sciences positions in Q1 2024 and 3 closed out, a net change of -1 holder.
  • The largest Tiziana Life Sciences buyer in Q1 2024 was Envestnet Asset Management, an estimated $8.8K added.
  • The largest Tiziana Life Sciences seller in Q1 2024 was Cubist Systematic Strategies, an estimated $6.78K sold.

Based on aggregated 13F filings for Q1 2024.